PMBI Poliwogg Medical Breakthroughs Index

The Index is a portfolio of small and mid-cap biotechnology and pharmaceutical stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials. The Index includes stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion.

As of 08/15/2022

Index Information
Provider:     S-Network Global Indexes
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Country:      USA
Currency:    USD
Inception date:  01/27/2006
Backtesting data exists:   No
Weighting methodology:   Market capitalization
Number of holdings:  90  (as of 09/15/2017)

As explained in what is an index, there is no universal system of giving an index a symbol. You can search for indexes using our index symbol lookup.

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy